WASHINGTON, May 7 (UPI) -- The U.S. Food and Drug Administration says it will require makers of two prescription testosterone gel products to add boxed warnings to their labels.
WASHINGTON, Feb. 26 (UPI) -- The U.S. Food and Drug Administration is ordering manufacturers of the drug metoclopramide to add a boxed warning about the drug's side effects.
WASHINGTON, Oct. 16 (UPI) -- The U.S. Food and Drug Administration says it has approved labeling changes for the psoriasis drug Raptiva, including a warning about infection risks.
WASHINGTON, Sept. 23 (UPI) -- The U.S. Food and Drug Administration is warning companies marketing unapproved products to stop manufacturing and marketing or face charges.
WASHINGTON, March 27 (UPI) -- The U.S. Food and Drug Administration has announced safety reviews of the FDA-approved medications Regranex Gel, Ziagen and Videx.
CLEVELAND, Nov. 7 (UPI) -- U.S. medical experts have been unable to find an approved and successful medication that will help a woman overcome a marked drop in sexual drive.
WASHINGTON, Aug. 15 (UPI) -- The U.S. Food and Drug Administration said manufacturers of certain type 2 diabetes drugs have agreed to add a stronger heart failure warning on drug labels.
WASHINGTON, Aug. 9 (UPI) -- The U.S. Food and Drug Administration warned consumers Thursday to avoid three red yeast rice products sold as treatments for high cholesterol.
WASHINGTON, Feb. 21 (UPI) -- The U.S. Food and Drug Administration ordered Genentech Inc. to add a boxed warning to its asthmatic drug marketed as Xolair.
WASHINGTON, Feb. 12 (UPI) -- The U.S. Food and Drug Administration ordered revised labeling for the antibiotic Ketek (telithromycin) to improve the safe use of the drug.
